Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics
Y Kanai - Pharmacology & therapeutics, 2022 - Elsevier
Cancer cells require a massive supply of nutrients, including sugars and amino acids—the
upregulation of transporters for each nutrient contributes to meet the demand. Distinct from …
upregulation of transporters for each nutrient contributes to meet the demand. Distinct from …
The human SLC7A5 (LAT1): the intriguing histidine/large neutral amino acid transporter and its relevance to human health
SLC7A5, known as LAT1, belongs to the APC superfamily and forms a heterodimeric amino
acid transporter interacting with the glycoprotein CD98 (SLC3A2) through a conserved …
acid transporter interacting with the glycoprotein CD98 (SLC3A2) through a conserved …
The L-type amino acid transporter LAT1—An emerging target in cancer
P Häfliger, RP Charles - International journal of molecular sciences, 2019 - mdpi.com
Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are
highly dependent on nutrients in order to duplicate their cell mass during each cell division …
highly dependent on nutrients in order to duplicate their cell mass during each cell division …
Amino acid transporters as targets for cancer therapy: why, where, when, and how
S Bröer - International journal of molecular sciences, 2020 - mdpi.com
Amino acids are indispensable for the growth of cancer cells. This includes essential amino
acids, the carbon skeleton of which cannot be synthesized, and conditionally essential …
acids, the carbon skeleton of which cannot be synthesized, and conditionally essential …
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc
Y Lee, P Wiriyasermkul, C Jin, L Quan… - Nature structural & …, 2019 - nature.com
The L-type amino acid transporter 1 (LAT1 or SLC7A5) transports large neutral amino acids
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …
Phenotypic profiling of solute carriers characterizes serine transport in cancer
V Papalazarou, AC Newman, A Huerta-Uribe… - Nature …, 2023 - nature.com
Serine is a vital amino acid in tumorigenesis. While cells can perform de novo serine
synthesis, most transformed cells rely on serine uptake to meet their increased biosynthetic …
synthesis, most transformed cells rely on serine uptake to meet their increased biosynthetic …
LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer
Drosophila Lgl and its mammalian homologues, LLGL1 and LLGL2, are scaffolding proteins
that regulate the establishment of apical–basal polarity in epithelial cells,. Whereas Lgl …
that regulate the establishment of apical–basal polarity in epithelial cells,. Whereas Lgl …
Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1
N Singh, GF Ecker - International journal of molecular sciences, 2018 - mdpi.com
The large neutral amino acid transporter 1 (LAT1, or SLC7A5) is a sodium-and pH-
independent transporter, which supplies essential amino acids (eg, leucine, phenylalanine) …
independent transporter, which supplies essential amino acids (eg, leucine, phenylalanine) …
Simple but efficacious enrichment of integral membrane proteins and their interactions for in-depth membrane proteomics
P Kongpracha, P Wiriyasermkul, N Isozumi… - Molecular & Cellular …, 2022 - ASBMB
Membrane proteins play essential roles in various cellular processes, such as nutrient
transport, bioenergetic processes, cell adhesion, and signal transduction. Proteomics is one …
transport, bioenergetic processes, cell adhesion, and signal transduction. Proteomics is one …
Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 …
Background Tumor angiogenesis is regarded as a rational anti-cancer target. The efficacy
and indications of anti-angiogenic therapies in clinical practice, however, are relatively …
and indications of anti-angiogenic therapies in clinical practice, however, are relatively …